查看购物车
  • Traditional Chinese
  • English
2021-2031年北美类器官市场报告：范围、细分、动态和竞争分析
市场调查报告书
商品编码
1871517

2021-2031年北美类器官市场报告：范围、细分、动态和竞争分析

North America Organoids Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 197 Pages | 订单完成后即时交付

价格

预计北美类器官市场将大幅成长，到 2031 年将达到约 65.7444 亿美元，高于 2023 年的 13.5719 亿美元，2023 年至 2031 年的年复合成长率(CAGR) 为 21.8%。

执行摘要和市场分析

北美类器官市场主要分为三大区域：美国、加拿大和墨西哥。截至2023年，美国在该市场占据主导地位，这主要得益于慢性疾病和病毒感染的日益普遍、类器官模型的商业化、研发活动的增加以及干细胞研究的进步。此外，类器官研究的资助和经费增加也进一步推动了市场成长。

市场区隔分析

北美类器官市场可以透过多种细分市场进行分析，包括类型、应用、来源、供应和方法：

  • 类型：市场依类器官来源可分为肠道、肝臟、胃、胰臟、肺、脑、肾臟等。 2023年，肠道类器官占据最大的市场份额。
  • 应用领域：类器官的应用领域包括发育生物学、传染病病理学、再生医学、药物毒性和疗效测试、药物研发、个人化医疗等。 2023年，发育生物学应用领域占据市场主导地位。
  • 资料来源：市场分为源自多能干细胞的类器官和源自器官特异性成体干细胞的类器官，其中多能干细胞在 2023 年将占据更大的市场份额。
  • 产品/服务：此业务板块包括仪器、耗材和服务，其中耗材在 2023 年是最大的业务板块。仪器又分为设备和仪器，而耗材包括感测器和其他物品。
  • 方法：类器官培养方法包括微图案化培养板、超低吸附培养板、悬滴法、微滴法或乳液法等。其中，悬滴法在2023年最为突出。

市场展望

技术进步正推动类器官与晶片器官技术的融合，从而增强其在生物学和生物医学研究中的应用，尤其是在疾病建模和临床药物筛选方面。类器官与晶片器官系统的结合正在改变癌症研究范式，并带来实际的临床效益。类器官与晶片器官和3D生物列印技术的协同应用，使得建构先进的癌症模型成为可能，从而能够研究肿瘤-基质相互作用、多器官肿瘤转移以及癌症微环境动态变化。

将多个类器官整合到单一晶片上的晶片类器官系统，是一个极具潜力的新兴领域。这种创新方法能够对多器官肿瘤转移及其在癌症微环境中的相互作用进行全面研究。近期的进展已成功建构出脑、肝、肠类器官晶片，预示该领域拥有广阔的发展前景。

国家概况

北美类器官市场主要由美国、加拿大和墨西哥所构成，其中美国在2023年占据最大的市场份额。类器官正在突破生物医学研究的现有限制，为人类发育提供新的见解，建构精准的疾病模型，并产生用于再生医学的患者特异性组织。哈佛大学维斯研究所和杜克大学等机构进行的杰出研究项目，已成功开发出支持卵子成熟的人类卵巢类器官，并有望用于治疗不孕症和卵巢癌。这项技术已授权给Gameto公司，并正被用于开发治疗女性生殖健康问题的疗法。此外，辛辛那提儿童医院干细胞和类器官医学中心（CuSTOM）正致力于透过创新的干细胞技术和类器官来推广个人化再生疗法，旨在建立用于治疗的患者特异性组织。

公司简介

类器官市场的主要参与者包括 STEMCELL Technologies Inc.、Molecular Devices, LLC、Hubrecht Organoid Technology、Definigen、Organoid Therapeutics、Thermo Fisher Scientific Inc.、Corning Inc.、Merck KGaA、InSphero、ACRO Biosystems、Bio-Techne Corp.、SUNGAN SCI. AG、3D Biotek LLC、Prellis Biologics Inc.、3Dnamics Inc. 和 Cellesce Ltd.。这些公司正在采用各种策略，包括扩张、产品创新以及併购，以增强其市场份额并为消费者提供创新解决方案。

目录

第一章：引言

第二章：执行概要

  • 关键见解

第三章：研究方法

  • 二手研究
  • 初步研究
    • 假设的提出：
    • 宏观经济因素分析：
    • 发展基础数字：
    • 数据三角测量：
    • 国家层面资料：

第四章：北美类器官市场－主要市场动态

  • 市场驱动因素
    • 对肿瘤建模和生物样本库的需求日益增长
    • 个人化药物的广泛应用
  • 市场限制
    • 缺乏熟练的专业人才
  • 市场机会
    • 重点关注药物发现活动
  • 未来趋势
    • 类器官与晶片器官的结合
  • 驾驶员和安全带的影响：

第五章：类器官市场－北美分析

  • 2021-2031年北美类器官市场收入
  • 北美类器官市场预测分析

第六章：北美类器官市场分析－依类型

  • 肠
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第七章：北美类器官市场分析－按应用领域划分

  • 发育生物学疾病
  • 传染病病理学
  • 再生医学
  • 药物毒性和疗效测试
  • 药物发现与个人化医疗
  • 其他的

第八章：北美类器官市场分析－依来源划分

  • 多能干细胞
  • 器官特异性成体干细胞

第九章：北美类器官市场分析－依产品类型划分

  • 仪器
  • 消耗品
  • 服务

第十章：北美类器官市场分析－依方法划分

  • 微图案板
  • 超低附件板
  • 悬垂
  • 微滴或乳液
  • 其他的

第十一章：北美类器官市场－国家分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第十二章：行业概况

  • 概述
  • 类器官市场成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十三章：公司简介

  • STEMCELL Technologies Inc
  • Molecular Devices, LLC.
  • Hubrecht Organoid Technology
  • Definigen
  • Organoid Therapeutics
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero
  • ACRO Biosystems.
  • Bio-Techne Corp
  • SUN bioscience SA
  • ORGANOID SCIENCES Co., Ltd.
  • Crown Bioscience Inc
  • Sartorius AG
  • 3D Biotek LLC
  • Prellis Biologics Inc.
  • 3Dnamics Inc.
  • Cellesce Ltd

第十四章：附录

Product Code: TIPRE00018845

The North America organoids market is projected to grow significantly, reaching approximately USD 6,574.44 million by 2031, up from USD 1,357.19 million in 2023, reflecting a compound annual growth rate (CAGR) of 21.8% from 2023 to 2031.

Executive Summary and Market Analysis

The North America organoids market is divided into three main regions: the United States, Canada, and Mexico. As of 2023, the United States dominates the market, driven by an increasing prevalence of chronic diseases and viral infections, the commercialization of organoid models, heightened research and development activities, and advancements in stem cell research. Additionally, the rise in grants and funding for organoid research is further fueling market growth.

Market Segmentation Analysis

The North America organoids market can be analyzed through various segments, including type, application, source, offering, and method:

  • Type: The market is categorized into organoids derived from the intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2023, intestinal organoids held the largest market share.
  • Application: The applications of organoids are segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery, personalized medicine, and others. Developmental biology applications led the market in 2023.
  • Source: The market is divided into organoids sourced from pluripotent stem cells and organ-specific adult stem cells, with pluripotent stem cells holding a larger market share in 2023.
  • Offering: This segment includes instruments, consumables, and services, with consumables being the largest segment in 2023. Instruments are further divided into devices and equipment, while consumables include sensors and other items.
  • Method: The methods used in organoid development include micropatterned plates, ultralow attachment plates, hanging drop, microdroplet or emulsion techniques, and others. The hanging drop method was the most prominent in 2023.

Market Outlook

Technological advancements are paving the way for integrating organoids with organ-on-a-chip technologies, enhancing applications in biological and biomedical research, particularly in disease modeling and clinical drug screening. Organoids combined with organ-on-a-chip systems are transforming cancer research paradigms and offering tangible clinical benefits. The collaborative use of organoids with organ-on-a-chip and 3D bioprinting is enabling the creation of advanced cancer models to investigate tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment dynamics.

The development of organoid-on-a-chip systems, which incorporate multiple organoids on a single chip, is an emerging area with significant potential. This innovative approach allows for comprehensive studies of multiorgan tumor metastases and interactions within the cancer microenvironment. Recent advancements have led to the creation of brain, liver, and intestinal organoids-on-chip, indicating a promising future for this segment.

Country Insights

The North American organoids market is primarily represented by the US, Canada, and Mexico, with the US holding the largest market share in 2023. Organoids are overcoming previous limitations in biomedical research, providing insights into human development, creating accurate disease models, and generating patient-specific tissues for regenerative medicine. Notable research initiatives, such as those at the Wyss Institute at Harvard University and Duke University, have led to the development of human ovarian organoids that support egg maturation, potentially aiding in treatments for infertility and ovarian cancer. This technology, licensed to Gameto, is being utilized to develop therapeutics for female reproductive health issues. Furthermore, the Center for Stem Cell and Organoid Medicine (CuSTOM) at Cincinnati Children's Hospital is advancing personalized regenerative therapies through innovative stem cell technologies and organoids, aiming to engineer patient-specific tissues for therapeutic use.

Company Profiles

Key players in the organoids market include STEMCELL Technologies Inc., Molecular Devices, LLC, Hubrecht Organoid Technology, Definigen, Organoid Therapeutics, Thermo Fisher Scientific Inc., Corning Inc., Merck KGaA, InSphero, ACRO Biosystems, Bio-Techne Corp, SUN bioscience SA, ORGANOID SCIENCES Co., Ltd., Crown Bioscience Inc., Sartorius AG, 3D Biotek LLC, Prellis Biologics Inc., 3Dnamics Inc., and Cellesce Ltd. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and deliver innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Organoids Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 4.1.2 Surging Adoption of Personalized Drugs
  • 4.2 Market Restraints
    • 4.2.1 Dearth of Skilled Professionals
  • 4.3 Market Opportunities
    • 4.3.1 Focus on Drug Discovery Activities
  • 4.4 Future Trends
    • 4.4.1 Combination of Organoids and Organ-on-a-Chip
  • 4.5 Impact of Drivers and Restraints:

5. Organoids Market - North America Analysis

  • 5.1 North America Organoids Market Revenue (US$ Million), 2021-2031
  • 5.2 North America Organoids Market Forecast Analysis

6. North America Organoids Market Analysis - by Type

  • 6.1 Intestine
    • 6.1.1 Overview
    • 6.1.2 Intestine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Liver
    • 6.2.1 Overview
    • 6.2.2 Liver: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Stomach
    • 6.3.1 Overview
    • 6.3.2 Stomach: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Pancreas
    • 6.4.1 Overview
    • 6.4.2 Pancreas: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Lung
    • 6.5.1 Overview
    • 6.5.2 Lung: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Brain
    • 6.6.1 Overview
    • 6.6.2 Brain: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.7 Kidney
    • 6.7.1 Overview
    • 6.7.2 Kidney: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. North America Organoids Market Analysis - by Application

  • 7.1 Developmental Biology Disease
    • 7.1.1 Overview
    • 7.1.2 Developmental Biology Disease: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Pathology of Infectious Disease
    • 7.2.1 Overview
    • 7.2.2 Pathology of Infectious Disease: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Regenerative Medicine
    • 7.3.1 Overview
    • 7.3.2 Regenerative Medicine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Drug Toxicity and Efficacy Testing
    • 7.4.1 Overview
    • 7.4.2 Drug Toxicity and Efficacy Testing: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Drug Discovery and Personalized Medicine
    • 7.5.1 Overview
    • 7.5.2 Drug Discovery and Personalized Medicine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Organoids Market Analysis - by Source

  • 8.1 Pluripotent Stem Cells
    • 8.1.1 Overview
    • 8.1.2 Pluripotent Stem Cells: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Organ-Specific Adult Stem Cell
    • 8.2.1 Overview
    • 8.2.2 Organ-Specific Adult Stem Cell: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Organoids Market Analysis - by Offering

  • 9.1 Instruments
    • 9.1.1 Overview
    • 9.1.2 Instruments: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Consumables
    • 9.2.1 Overview
    • 9.2.2 Consumables: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Services
    • 9.3.1 Overview
    • 9.3.2 Services: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Organoids Market Analysis - by Method

  • 10.1 Micropatterned Plates
    • 10.1.1 Overview
    • 10.1.2 Micropatterned Plates: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.2 Ultralow Attachment Plates
    • 10.2.1 Overview
    • 10.2.2 Ultralow Attachment Plates: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.3 Hanging Drop
    • 10.3.1 Overview
    • 10.3.2 Hanging Drop: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.4 Microdroplet or Emulsion
    • 10.4.1 Overview
    • 10.4.2 Microdroplet or Emulsion: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. North America Organoids Market - Country Analysis

  • 11.1 North America
    • 11.1.1 North America Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 North America Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 United States: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.2.1 United States: North America Organoids Market Share - by Type
        • 11.1.1.2.2 United States: North America Organoids Market Share - by Application
        • 11.1.1.2.3 United States: North America Organoids Market Share - by Source
        • 11.1.1.2.4 United States: North America Organoids Market Share - by Offering
        • 11.1.1.2.5 United States: North America Organoids Market Share - by Instruments
        • 11.1.1.2.6 United States: North America Organoids Market Share - by Consumables
        • 11.1.1.2.7 United States: North America Organoids Market Share - by Method
      • 11.1.1.3 Canada: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.3.1 Canada: North America Organoids Market Share - by Type
        • 11.1.1.3.2 Canada: North America Organoids Market Share - by Application
        • 11.1.1.3.3 Canada: North America Organoids Market Share - by Source
        • 11.1.1.3.4 Canada: North America Organoids Market Share - by Offering
        • 11.1.1.3.5 Canada: North America Organoids Market Share - by Instruments
        • 11.1.1.3.6 Canada: North America Organoids Market Share - by Consumables
        • 11.1.1.3.7 Canada: North America Organoids Market Share - by Method
      • 11.1.1.4 Mexico: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.4.1 Mexico: North America Organoids Market Share - by Type
        • 11.1.1.4.2 Mexico: North America Organoids Market Share - by Application
        • 11.1.1.4.3 Mexico: North America Organoids Market Share - by Source
        • 11.1.1.4.4 Mexico: North America Organoids Market Share - by Offering
        • 11.1.1.4.5 Mexico: North America Organoids Market Share - by Instruments
        • 11.1.1.4.6 Mexico: North America Organoids Market Share - by Consumables
        • 11.1.1.4.7 Mexico: North America Organoids Market Share - by Method

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Organoids Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 STEMCELL Technologies Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Molecular Devices, LLC.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Hubrecht Organoid Technology
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Definigen
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Organoid Therapeutics
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Thermo Fisher Scientific Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Merck KGaA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 InSphero
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ACRO Biosystems.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Techne Corp
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 SUN bioscience SA
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 ORGANOID SCIENCES Co., Ltd.
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Crown Bioscience Inc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Sartorius AG
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 3D Biotek LLC
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Prellis Biologics Inc.
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 3Dnamics Inc.
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments
  • 13.19 Cellesce Ltd
    • 13.19.1 Key Facts
    • 13.19.2 Business Description
    • 13.19.3 Products and Services
    • 13.19.4 Financial Overview
    • 13.19.5 SWOT Analysis
    • 13.19.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners

List Of Tables

  • Table 1. North America Organoids Market Segmentation
  • Table 2. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Offering
  • Table 7. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Method
  • Table 8. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 9. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 10. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 11. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 12. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 13. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 14. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 15. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 16. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 19. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 20. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 21. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 22. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 23. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 24. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 25. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 26. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 27. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 28. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 29. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 30. Recent Organic Growth Strategies in Organoids Market
  • Table 31. Recent Inorganic Growth Strategies in the Organoids Market

List Of Figures

  • Figure 1. North America Organoids Market Segmentation - Country
  • Figure 2. North America Organoids Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Organoids Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Organoids Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Liver: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Stomach: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Pancreas: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Lung: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Brain: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Kidney: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. North America Organoids Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Regenerative Medicine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. North America Organoids Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Organ-Specific Adult Stem Cell: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. North America Organoids Market Share (%) - by Offering (2023 and 2031)
  • Figure 25. Instruments: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Consumables: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Services: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. North America Organoids Market Share (%) - by Method (2023 and 2031)
  • Figure 29. Micropatterned Plates: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Ultralow Attachment Plates: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. Hanging Drop: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. Microdroplet or Emulsion: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. North America Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 35. United States: North America Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 36. Canada: North America Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 37. Mexico: North America Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 38. Growth Strategies in Organoids Market